STUDY OF THE EFFECT OF 0.01% ATROPINE EYE DROP ON MYOPIA PROGRESSION AND INTRAOCULAR PRESSURE

Authors

Dr. Prakhar Saxena , Dr. Prachi Shukla , Dr. Suman Bhartiya , Dr. Yashika Sinha , Dr. Narendra Singh Author

Keywords:

Keywords: Myopia, Refractive error, 0.01% Atropine, IOP, Children.

Abstract

Background: Myopia, a prevalent refractive error in children, poses
significant public health concerns due to its increasing incidence and
potential complications. Low-dose atropine (0.01%) has emerged as a
promising treatment option to slow myopia progression.
Aim and Objectives: This study aimed to evaluate the efficacy of
0.01% atropine eye drops on myopia progression and intraocular
pressure (IOP) in children under 16 years of age.
Materials and Methods: Conducted at Muzaffarnagar Medical
College over 12 months, 150 myopic children were randomly assigned
to receive either 0.01% atropine or placebo. Comprehensive ocular
examinations assessed refraction changes, IOP measurements, and any
adverse effects.
Results: The atropine group demonstrated a statistically significant
reduction in myopia progression compared to the placebo group, with
no adverse effects on IOP.
Conclusion:The findings suggest that 0.01% atropine is an effective
and safe treatment for slowing myopia progression in children,
warranting further research into its long-term effects.